RxDoctor Payments Data

Thiruvengadam Muniraj, MD

Gastroenterology · New Haven, CTNPI 1033436530

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 97.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $19,926 and has fallen 59.8% since, to $8,012 in 2025. Among gastroenterology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,140in general payments, 2019–2025

Across 83 payments — averaging $543.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$44K
  • Medtronic$416
  • Cook Medical LLC$247
  • Apollo Endosurgery US Inc$182
  • Alcresta Therapeutics, Inc.$102
  • W. L. Gore & Associates, Inc.$95
  • plus $112 from 3 others
$24,710in research payments, 2019–2025

Across 8 payments — averaging $3088.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$25K

What the payments were for

  • Consulting fees$15,00033%
  • Speaking & faculty fees$22,62550%
  • Travel & lodging$3,6288%
  • Food & beverage$3,8869%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,140 in reported general payments places this provider in the 90th percentile of 326 gastroenterology providers in Connecticut.

See all gastroenterology providers in Connecticut

Medicare billing

Part B allowed, 2024
$127,826
Medicare patients
291
Services billed
572

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase29$50,285
Omeprazole14$576
Pantoprazole Sodium52$534
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl31$384
Ciprofloxacin Hcl41$244

Paid to pharmacies, not to this prescriber.

Other gastroenterology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →